Viewing Study NCT00750334


Ignite Creation Date: 2025-12-25 @ 2:40 AM
Ignite Modification Date: 2025-12-26 @ 1:18 AM
Study NCT ID: NCT00750334
Status: TERMINATED
Last Update Posted: 2015-05-21
First Post: 2008-09-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS)
Sponsor: Genzyme, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module